Trademark owner · USPTO register · rebuilt nightly

Juno Therapeutics, Inc.

81 live US trademarks, filing since 2016. 39 new applications filed this year.

Live marks
81
registered + pending
Registered
7
on the Principal Register
Pending
74
20 open to opposition
Filed in 2026
39
23 intent to use
Classes used
3
of 45 Nice classes
First filing
2016
10 years on the register
At a glanceplain-language reads of the register
Mostly pharmaceuticals: 77 of 81 live marks are in Class 5. Medical & beauty services (Class 44) is next with 3.
Filing faster than usual: 39 applications so far in 2026 against a yearly average of 5.6.
New products ahead: 23 of the 39 filings this year are intent-to-use applications, meaning the goods are not yet on sale.
20 marks are open to opposition now; the windows close between Nov 12 and Nov 19.
2 registrations have a maintenance filing due in the next 12 months.
Filing activityapplications per year, by filing date
0 49 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 40 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50.

Latest activity

What Juno Therapeutics, Inc. filed most recently.

MarkClassFiledBasisStatusSerial
WELKARZO 5 Sep 24, 2026 — pending 50127024
RYZEWELVO 5 Jul 16, 2026 — pending 99943977
RYZEWELZI 5 Jul 16, 2026 — pending 99944009
WELCARYO 5 Jul 16, 2026 intent to use published · closes Nov 26 99944011
WELCARZO 5 Jul 16, 2026 intent to use published · closes Nov 26 99944013
WELQARZO 5 Jul 16, 2026 intent to use published · closes Nov 26 99944016
ZOLCARTIQ 5 Jul 16, 2026 intent to use published · closes Nov 26 99944018
AUVAMTRI 5 Jul 10, 2026 intent to use published · closes Nov 26 99934110
AUVIMSEO 5 Jul 10, 2026 intent to use published · closes Nov 26 99934148
BRAVUPDA 5 Jul 10, 2026 intent to use published · closes Nov 26 99934157
Open to opposition now30-day windows from publication
BRYNWELO · Cl. 5 · published Oct 13
closes Nov 12
KARTZAU · Cl. 5 · published Oct 13
closes Nov 12
MUZEGTO · Cl. 5 · published Oct 13
closes Nov 12
MURIDURV · Cl. 5 · published Oct 13
closes Nov 12
OBREKLIO · Cl. 5 · published Oct 13
closes Nov 12
OQARTLEE · Cl. 5 · published Oct 13
closes Nov 12
RIMMZOLV · Cl. 5 · published Oct 13
closes Nov 12
BRAIKWAY · Cl. 5 · published Oct 20
closes Nov 19
RIAJUS · Cl. 5 · published Oct 20
closes Nov 19
RYAJUS · Cl. 5 · published Oct 20
closes Nov 19
SETNEWA · Cl. 5 · published Oct 20
closes Nov 19
SETNULA · Cl. 5 · published Oct 20
closes Nov 19
VOXTIMZO · Cl. 5 · published Oct 20
closes Nov 19
ZOTAYLU · Cl. 5 · published Oct 20
closes Nov 19
ZOLVIVRY · Cl. 5 · published Oct 20
closes Nov 19
WELZOQAR · Cl. 5 · published Oct 20
closes Nov 19
NIMMUCARTZ · Cl. 5 · published Oct 20
closes Nov 19
KARZOLV · Cl. 5 · published Oct 20
closes Nov 19
BRYZUPTI · Cl. 5 · published Oct 20
closes Nov 19
AUTIMMCA · Cl. 5 · published Oct 20
closes Nov 19

Anyone who believes they would be harmed by registration can oppose during this window.

Maintenance windows aheadnext 12 months · from registration dates
JUNO THERAPEUTICS · Reg. 6,228,218 · registered Dec 2020
Section 8 declaration (years 5–6)
Dec 22, 2025 → Dec 22, 2026
JUNO THERAPEUTICS · Reg. 6,228,219 · registered Dec 2020
Section 8 declaration (years 5–6)
Dec 22, 2025 → Dec 22, 2026

A filing missed by the due date enters a six-month grace period, then the registration cancels.

Other large filers in Class 5Full ranking →
Names on the registerwhat this page merges, and what it leaves out
Juno Therapeutics, Inc. · 81 live marks
included
Juno Beauty, Inc. · 25 live marks · may be a related company
separate page

Spellings are merged when they differ only in punctuation or legal suffix. Anything else stays separate rather than guessed.

Common questions

About Juno Therapeutics, Inc. trademarks.

How many trademarks does Juno Therapeutics, Inc. have?

81 live US trademarks as of October 23, 2026: 7 registered and 74 pending applications. 39 were filed in 2026 so far.

What does Juno Therapeutics, Inc. sell, according to its trademarks?

Mostly pharmaceuticals (Class 5, 77 live marks). Also medical & beauty services (Class 44) and science & technology (saas) (Class 42).

Who owns the BREYANZI trademark?

BREYANZI is owned by Juno Therapeutics, Inc.. It was registered on March 26, 2019 (Reg. No. 5709663) and is live. The same owner holds 80 other live US marks.

When did Juno Therapeutics, Inc. first file a trademark?

Its oldest live US filing dates from 2016: JUNO THERAPEUTICS, filed February 1, 2016.

Know the morning after Juno Therapeutics, Inc. files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.